Scarica l'app Stockscreener
110.56
0.66%
-0.74
Dopo l'orario di chiusura:
111.00
0.44
+0.40%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
T Rowe Price Group Inc Borsa (TROW) Ultime notizie
T. Rowe Price (TROW) Q2 2026 Earnings Call Transcript - AOL.com
T. Rowe Price Group (NASDAQ:TROW) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
D.A. Davidson & CO. Has $6.46 Million Stake in T. Rowe Price Group, Inc. $TROW - MarketBeat
T. Rowe Price (TROW) Reworks Leadership To Speed AI Push And Back Crypto - Yahoo Finance
TROW|T Rowe Price Group Inc|Price:110.560|Chg%:-0.740 - TradingKey
T. Rowe Price Associates (THG) discloses 5.2% Hanover Insurance ownership stake - Stock Titan
T. Rowe Price (MLTX holder) discloses 5.3% MoonLake Immunotherapeutics position - Stock Titan
T. Rowe Price Investment Management (PRAA) discloses 7.9% PRA Group ownership - Stock Titan
T. Rowe Price (VICR) discloses 7.0% beneficial stake in Vicor common stock - Stock Titan
T. Rowe Price Associates (MDWD) discloses 5.0% ownership in Mediwound common stock - Stock Titan
T. Rowe Price Investment Management (PCTY) discloses 5.8% Paylocity ownership in 13G/A - Stock Titan
T. Rowe Price (SVV) discloses 7.39M-share position in Savers Value Village - Stock Titan
T. Rowe Price Investment Management (AIZ) reports 4.9% Assurant stake in 13G/A - Stock Titan
T. Rowe Price Investment Management (MTSI) discloses 2.85M MACOM shares in 13G/A - Stock Titan
T. Rowe Price (UNIT) discloses 5.0% Uniti Group ownership in Schedule 13G/A - Stock Titan
T. Rowe Price Investment Management (GHM) discloses 5.2% Graham Corp ownership - stocktitan.net
T. Rowe Price Investment Management (USCB) discloses 8.6% ownership of USCB Financial - Stock Titan
T. Rowe Price Investment Management (GLNG) discloses 6.2% Golar LNG common stock holding - Stock Titan
T. Rowe Price Investment Management (TFX) discloses 7.2% ownership in Teleflex - stocktitan.net
T. Rowe Price Investment Management (MIAX) discloses 5.3% holding in Miami International - Stock Titan
T. Rowe Price Investment Management (STTK) reports 15.3% stake in Shattuck Labs - Stock Titan
T. Rowe Price Investment Management (MPTI) discloses 5.9% holding in M-TRON Industries - stocktitan.net
T. Rowe Price updates 6.5% Safehold Inc. (SAFE) ownership in Schedule 13G/A - Stock Titan
T. Rowe Price Investment Management (BELFA) discloses 4.4% Bel Fuse Inc-CL B holding - Stock Titan
T. Rowe Price Investment Management (NI) discloses 6.2% beneficial stake in NiSource - stocktitan.net
T. Rowe Price Investment Management (DCBG) discloses 7.2% Dime Community stake - Stock Titan
T. Rowe Price Investment Management (PTC) discloses 13.1M-share position in PTC Inc. - Stock Titan
T. Rowe Price Investment Management (EQBK) discloses 11.4% Equity Bancshares ownership - Stock Titan
Cabaletta Bio (CABA): T. Rowe Price reports 11.6% common stock stake - Stock Titan
T. Rowe Price (STVN) cuts Stevanato stake to 3,921 shares, 0.0% - Stock Titan
T. Rowe Price Associates (HXL) discloses 5.86M-share position in Hexcel - Stock Titan
T. Rowe Price (WOLF) discloses 6.1M Wolfspeed shares held for clients - Stock Titan
T. Rowe Price (MQ) discloses 11.6% Marqeta stake; Mid-Cap Value Fund holds 5.1% - Stock Titan
Skyward Specialty (SKWD): T. Rowe Price Associates reports 6% ownership stake - Stock Titan
T. Rowe Price Associates (NTRA) discloses 9.0M-share Natera stake in updated 13G - Stock Titan
T. Rowe Price Associates (SMA) reports 5.27M-share, 9.5% stake in SmartStop - Stock Titan
T. Rowe Price Associates (VRDN) discloses 5.2% Viridian Therapeutics ownership in 13G - Stock Titan
T. Rowe Price (CCC) discloses 7.5% beneficial stake in CCC Intelligent Solutions - stocktitan.net
T. Rowe Price Associates (MRX) discloses 6.8% Marex Group holding in 13G - Stock Titan
T. Rowe Price Associates (SARO) discloses 13.6% holding in StandardAero Inc. - Stock Titan
T. Rowe Price stakes 5.6% in Keysight Technologies (KEYS) common stock - Stock Titan
T. Rowe Price reports 9.8M Old Dominion Freight Line (ODFL) shares - Stock Titan
T. Rowe Price Associates (AAP) reports 14% stake in Advance Auto Parts common stock - Stock Titan
T. Rowe Price (PEB) discloses 8.58M-share Pebblebrook Hotel Trust stake in 13G/A - Stock Titan
T. Rowe Price Associates (IBP) discloses 4.3% holding in Installed Building Products - stocktitan.net
T. Rowe Price Associates (TWST) discloses 3.63M-share Twist Bioscience position - Stock Titan
T. Rowe Price Associates (VRRM) reports 241,697 Verra Mobility shares in 13G/A - Stock Titan
T. Rowe Price (ARGX) discloses 2.68M argenx SE ADRs with 4.3% ownership - stocktitan.net
Cullinan Therapeutics (CGEM): T. Rowe Price reports 6.2% ownership stake - Stock Titan
T. Rowe Price Associates (KNF) reports 5.1M Knife River Corp shares, a 9% stake - Stock Titan
Shoals Technologies (SHLS): T. Rowe Price reports 12.9% ownership stake - Stock Titan
T. Rowe Price Associates (KMTS) discloses 4.97M Kestra Medical shares in 13G/A - Stock Titan
T. Rowe Price (FLOC) discloses 7.3% Flowco Holdings ownership stake - Stock Titan
Build-A-Bear Workshop (BBW): T. Rowe Price reports 5.3% ownership stake - Stock Titan
T. Rowe Price discloses 4.9% Guardant Health (GH) holding in 13G/A - Stock Titan
T. Rowe Price Associates (RNA) discloses 8.6% Atrium Therapeutics ownership in 13G/A - stocktitan.net
T. Rowe Price (MEDP) discloses 7.2% Medpace Holdings stake in latest filing - Stock Titan
TechnipFMC (FTI): T. Rowe Price Associates discloses 6.5% ownership stake - Stock Titan
T. Rowe Price Associates (ARRY) discloses 5.6% ownership in Array Technologies common stock - Stock Titan
T. Rowe Price Associates (CLDX) discloses 6.0% Celldex Therapeutics ownership on Schedule 13G - Stock Titan
T. Rowe Price (WAL holder) reports 6.3M Western Alliance shares in 13G/A - stocktitan.net
T. Rowe Price (NASDAQ: AMBA) discloses 5.9% Ambarella ownership in Schedule 13G - Stock Titan
T. Rowe Price Associates (CF) discloses 5.5% beneficial stake in CF Industries - Stock Titan
T. Rowe Price Associates (ST) discloses 9.53M Sensata shares in Schedule 13G/A - stocktitan.net
Repligen Corp (RGEN) stake at 3.1% in new T. Rowe Price 13G/A - Stock Titan
T. Rowe Price Associates (DGX) discloses 5.43M Quest Diagnostics shares in 13G/A - Stock Titan
T. Rowe Price (DSGX) discloses 6.6% Descartes Systems Group holding in 13G/A - Stock Titan
T. Rowe Price (NOVT) discloses 6.2% beneficial stake in Novanta common stock - Stock Titan
T. Rowe Price (WING) reports 0.5% Wingstop stake in updated holding - Stock Titan
T. Rowe Price Associates (NYSE: HEI) discloses 5.8% HEICO ownership on Schedule 13G - Stock Titan
T. Rowe Price Associates (SLM) discloses 6.6% beneficial stake in SLM Corp - Stock Titan
T. Rowe Price Associates (EHC) discloses 5.1% Encompass Health stake on Schedule 13G - Stock Titan
3.63%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):